Abstract:Coronary microvascular dysfunction (CMD) has been shown to contribute to cardiac hypertrophy and heart failure with preserved ejection fraction. At this point, there are no proven treatments for CMD. We have shown that histone acetylation may play a critical role in the regulation of CMD. By using a mouse model that replaces lysine with arginine at residues K98/117/161/162R of p53 (p534KR), preventing acetylation at these sites, we test the hypothesis that acetylation-deficient p534KR could improve coronary microvascular dysfunction and prevent the progression of hypertensive cardiac hypertrophy and heart failure. Wild-type (WT) and p534KR mice were subjected to pressure overload (PO) by transverse aortic constriction to induce cardiac hypertrophy and heart failure (HF). Echocardiography measurements revealed improved cardiac function together with reduction of apoptosis and fibrosis in p534KR mice. Importantly, myocardial capillary density and coronary flow reserve (CFR) were significantly improved in p534KR mice. Moreover, p534KR upregulated the expression of cardiac glycolytic enzymes and glucose transporters, as well as the level of fructose-2,6-biphosphate; increased PFK-1 activity; and attenuated cardiac hypertrophy. These changes were accompanied by increased expression of HIF-1α and proangiogenic growth factors. Additionally, the levels of SERCA-2 were significantly upregulated in sham p534KR mice as well as in p534KR mice after TAC. In vitro, p534KR significantly improved endothelial cell (EC) glycolytic function and mitochondrial respiration, and enhanced EC proliferation and angiogenesis. Similarly, acetylation-deficient p534KR significantly improved CFR and rescued cardiac dysfunction in SIRT3 KO mice. Our data reveal the importance of p53 acetylation in coronary microvascular function, cardiac function, and remodeling, and may provide a promising approach to improve hypertension-induced coronary microvascular dysfunction (CMD) and to prevent the transition of cardiac hypertrophy to heart failure.

Acetylation of P53 Protein at Lysine 120 Up-regulates Apaf-1 Protein and Sensitizes the Mitochondrial Apoptotic Pathway*

Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage.

Arginine Methylation of Hnrnp K Enhances P53 Transcriptional Activity.

Deacetylation of P53 Modulates Its Effect on Cell Growth and Apoptosis

Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.

Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression

Acetylation of TIP60 at K104 is Essential for Metabolic Stress-Induced Apoptosis in Cells of Hepatocellular Cancer.

Acetylation of P53 Augments Its Site-Specific DNA Binding Both in Vitro and in Vivo.

Deciphering the acetylation code of p53 in transcription regulation and tumor suppression

Acetylation Is Indispensable for p53 Activation

Acetylation Of P53 Inhibits Its Ubiquitination By Mdm2

Histone Deacetylases Specifically Down-regulate P53-Dependent Gene Activation

Functional Investigations of p53 Acetylation Enabled by Heterobifunctional Molecules

Regulation of Tip60‐dependent P53 Acetylation in Cell Fate Decision

Functional Analysis of the Acetylation of Human P53 in DNA Damage Responses

Dynamics of the p53 acetylation pathway.

Acetylation of p53 at Lysine 373/382 by the Histone Deacetylase Inhibitor Depsipeptide Induces Expression of p21 <sup>Waf1/Cip1</sup>

Acetylation of P53 at Lysine 373/382 by the Histone Deacetylase Inhibitor Depsipeptide Induces Expression of P21(waf1/cip1).

p53 β-hydroxybutyrylation attenuates p53 activity

Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation

P53 Acetylation Exerts Critical Roles In Pressure Overload Induced Coronary Microvascular Dysfunction and Heart Failure